Skip to main content

Advertisement

Log in

The prevalence of detrusor overactivity amongst patients with symptoms of overactive bladder: a retrospective cohort study

  • Original Article
  • Published:
International Urogynecology Journal Aims and scope Submit manuscript

Abstract

Introduction and hypothesis

Overactive bladder (OAB) is a symptom-based condition consisting of urgency, with or without incontinence, usually with frequency and nocturia. There are many potential causes of OAB, yet many patients are prescribed anticholinergic medications empirically. This study aimed to determine what proportion of patients presenting for urogynecologic assessment with symptoms of OAB had urodynamic detrusor overactivity (DO).

Methods

Retrospective chart review was performed for 220 consecutive patient referrals. Demographic data, physical exam information, and urodynamic results were collected. The t test and Fisher’s exact test were used for statistical analyses.

Results

The prevalence of DO was 11.8 % in this population. Urogenital atrophy and incomplete emptying were more common. Patients with DO were older and more often menopausal than those without DO. Significant prolapse was a common finding amongst patients with OAB symptoms.

Conclusions

Patients with symptoms of OAB should undergo pelvic examination and assessment of post-void residuals before being initiated on anticholinergic medication.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Abrams P, Cardozo L, Fall M et al (2002) The standardisation of terminology of lower urinary tract function: report from the Standarisation Sub-committee of the International Continence Society. Neurourol Urodyn 21(2):167–178

    Article  PubMed  Google Scholar 

  2. Irwin D, Milsom I, Hunskaar S et al (2006) Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol 50:1306–1315

    Article  PubMed  Google Scholar 

  3. Milsom I, Abrams P, Cardozo L, Roberts RG, Thüroff J, Wein AJ (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 87:760–766

    Article  PubMed  CAS  Google Scholar 

  4. Stewart WF, Van Rooyen JB, Cundiff GW et al (2003) Prevalence and burden of overactive bladder in the United States. World J Urol 20:327–336

    PubMed  CAS  Google Scholar 

  5. Wan H, Sengupta M, Velkoff VA, DeBarros KA (2005) 65+ in the United States. U.S. Census Bureau, Current Population Reports. U.S. Government Printing Office, Washington, DC, pp 23-209

  6. Irwin DE, Mungapen L, Milsom I et al (2009) The economic impact of overactive bladder syndrome in six Western countries. BJU Int 103:202–209

    Article  PubMed  Google Scholar 

  7. Resnick NM, Yalla SV, Laurino E (1989) The pathophysiology of urinary incontinence among institutionalized elderly persons. N Engl J Med 320(1):1–7

    Article  PubMed  CAS  Google Scholar 

  8. Drutz HP (2011) Overactive bladder: the importance of tailoring treatment to the individual patient. J Multidiscip Healthc 4:233–237

    PubMed  Google Scholar 

  9. Ashok K, Wang A (2010) Detrusor overactivity: an overview. Arch Gynecol Obstet 282:33–41

    Article  PubMed  Google Scholar 

  10. Digesu GA, Khuller V, Cardozo L, Salvatore S (2003) Overactive bladder symptoms: do we need urodynamics? Neurourol Urodyn 22:105–108

    Article  PubMed  Google Scholar 

  11. de Boer TA, Salvatore S, Cardozo L et al (2010) Pelvic organ prolapse and overactive bladder. Neurourol Urodyn 29(1):30–39

    Article  PubMed  Google Scholar 

  12. Johnston SL, Farrell SA, Bouchard C et al (2004) The detection and management of vaginal atrophy. J Obstet Gynaecol Can 26(5):503–508

    PubMed  Google Scholar 

  13. Hextall A, Cardozo L (2001) The role of estrogen supplementation in lower urinary tract dysfunction. Int Urogynecol J Pelvic Floor Dysfunct 12:258–261

    Article  PubMed  CAS  Google Scholar 

  14. Calleja-Agius J, Brincat MP (2009) Urogenital atrophy. Climacteric 12:279–285

    Article  PubMed  CAS  Google Scholar 

  15. Cody JD, Richardson K, Moehrer B, Hextall A, Glazener CMA. (2009) Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev 4:CD001405. doi:10.1002/14651858.CD001405.pub2

  16. Kupelian V, Rosen RC, Link CL et al (2009) Association of urological symptoms and chronic illness in men and women: contributions of symptom severity and duration–results from the BACH Survey. J Urol 181:694–700

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The Department of Obstetrics and Gynecology, Mount Sinai Hospital and University Health Network, Toronto provided funding.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P. Diamond.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Diamond, P., Hassonah, S., Alarab, M. et al. The prevalence of detrusor overactivity amongst patients with symptoms of overactive bladder: a retrospective cohort study. Int Urogynecol J 23, 1577–1580 (2012). https://doi.org/10.1007/s00192-012-1781-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00192-012-1781-4

Keywords

Navigation